Xeris Pharmaceuticals, Inc. is an innovative specialty pharmaceutical company based in Chicago, Illinois, focused on the development and commercialization of ready-to-use injectable and infusible drug formulations. Leveraging its proprietary formulation technology, Xeris aims to improve patient care by offering products that enhance the delivery and effectiveness of therapeutics across various therapeutic areas, including diabetes and cancer. With a commitment to addressing unmet medical needs, Xeris is well-positioned to capture market opportunities and drive growth in the evolving healthcare landscape.
Click "Analyze" to generate stock analysis
XERS Price Trend and Signals
XERS Option Volumes & Open Interests (aggregated)
XERS Put Call Ratios and IV (aggregated)
XERS Financials
2025-10-29Somewhat Bullishprice_signal
Yearly high detected.
2025-10-20Somewhat Bullishprice_signal
Yearly high detected.
2025-10-15Somewhat Bullishmacd_signal
Golden cross above zero detected.
2025-10-15Somewhat Bullishprice_signal
Yearly high detected.
2025-10-15Neutraloption_volume_signal
Abnormal option volume detected compared to 5-day moving average.
2025-10-15Neutraloption_volume_signal
Abnormal option volume detected compared to 10-day moving average.
2025-10-15Neutraloption_volume_signal
Abnormal option volume detected compared to 20-day moving average.
2025-10-15Neutraloption_volume_signal
Abnormal option volume detected compared to 3 mon moving average.